Effect of sperm-immobilizing antibodies bound to the surface of ejaculated human spermatozoa on sperm motility in immunologically infertile men.

H. Shibahara,Y. Hirano,S. Takamizawa,I. Sato

DOI: https://doi.org/10.1016/S0015-0282(02)04702-7

IF: 6.7

2003-03-01

Fertility and Sterility

Abstract:

What problem does this paper attempt to address?

Effects of Homocysteine on the Expression of Matrix Metalloproteinase-2 in Rat Vascular Smooth Muscle Cells

Yang-Bo XING,Hang-Yuan GUO,Xiao-Quan MA,Hong HE

DOI: https://doi.org/10.3969/j.issn.1007-3949.2006.06.012

2006-01-01

Abstract:Aim To explore the effects of homocysteine(Hcy) on the expression of matrix metalloproteinase-2(MMP-2) in rat vascular smooth muscle cells(VSMC). Methods Cultured rat VSMC was incubated with different concentration of Hcy in vitro for 24,48 and 72 h.The expression of MMP-2 was determined by using the methods of gelatin zymography and western blotting. Results 0.05～1.0 mmol/L Hcy increased the expression of MMP-2 significantly.Incubated with the same concentration of Hcy the level of MMP-2 of 72 h was higher than that of 24 h and 48 h. Hcy >5.0 mmol/L reduced the expression of MMP-2.Incubated with the same concentration of Hcy(>5.0 mmol/L) the level of MMP-2 of 72 h was lower than that of 24 h and 48 h. Conclusions These datas suggested that Hcy can affect the expression of MMP-2 in VSMC.It may be one of factors in the pathogenesis of atherosclerosis induced by Hcy.
Inhibitor of Hyaluronic Acid Synthesis 4-Methylumbelliferone Suppresses the Secretory Processes That Ensure the Invasion of Neutrophils into Tissues and Induce Inflammation

Svetlana I. Galkina,Natalia V. Fedorova,Alexander L. Ksenofontov,Ekaterina A. Golenkina,Marina V. Serebryakova,Vladimir I. Stadnichuk,Ludmila A. Baratova,Galina F. Sud’ina

DOI: https://doi.org/10.3390/biomedicines10020314

IF: 4.757

2022-01-28

Biomedicines

Abstract:Integrin-dependent adhesion of neutrophils to tissue, accompanied by the development of neutrophil-induced inflammation, occurs both in the focus of infection and in the absence of infection in metabolic disorders such as reperfusion after ischemia, diabetes mellitus, or the development of pneumonia in patients with cystic fibrosis or viral diseases. Hyaluronic acid (HA) plays an important role in the recruitment of neutrophils to tissues. 4-methylumbilliferon (4-MU), an inhibitor of HA synthesis, is used to treat inflammation, but its mechanism of action is unknown. We studied the effect of 4-MU on neutrophil adhesion and concomitant secretion using adhesion to fibronectin as a model for integrin-dependent adhesion. 4-MU reduced the spreading of neutrophils on the substrate and the concomitant secretion of granule proteins, including pro-inflammatory components. 4-MU also selectively blocked adhesion-induced release of the free amino acid hydroxylysine, a product of lysyl hydroxylase, which can influence cell invasion by modifying the extracellular matrix. Finally, 4-MU inhibited the formation of cytonemes, the extracellular membrane secretory structures containing the pro-inflammatory bactericides of the primary granules. The anti-inflammatory effect of 4-MU may be associated with the suppression of secretory processes that ensure the neutrophil invasion and initiate inflammation. We suggest that HA, due to the peculiarities of its synthesis, can promote the release of secretory carriers from the cell and 4-MU can block this process.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
198 HYALURONAN IS REQUIRED FOR SMOOTH MUSCLE CELL DIFFERENTIATION FROM STEM CELLS

R. Simpson,X. Hong,Q. Xu

DOI: https://doi.org/10.1136/heartjnl-2013-304019.198

IF: 5.7

2013-01-01

Heart

Abstract:Background Emerging evidence indicates that the mobilization and recruitment of circulating or tissue-resident stem/progenitor cells give rise to smooth muscle cells (SMCs) which participate in numerous cardiovascular diseases. Understanding the regulatory mechanisms that control SMC differentiation and their recruitment from vascular progenitors is essential for stem cell therapy for vascular diseases and regenerative medicine. Hyaluronan (HA) is a linear glycosominoglycan and ubiquitous component of the intercellular matrix; the identification of HA as a critical component of the stem cell niche led us to investigate its role in regulating stem cell differentiation. Methods and Results Stem cells were seeded on collagen-IV-coated flasks and cultured in differentiation medium to induce SMC differentiation as demonstrated by the expression of SMC-specific genes smooth muscle α-actin, calponin, SM22-α and smooth muscle myosin heavy chain. These phenotypic changes coincided with dynamic changes in HA synthesis and organization. It was demonstrated that SMC differentiation was associated with increased HA synthase (HAS)2 expression, extracellular HA synthesis and loss of pericellular HA. Inhibition of HA synthesis by hyaluronidase, 4-methylumbelliferone (4MU), or specific gene silencing of HAS2 led to abrogation of SMC marker expression. Furthermore, It was found that SMC differentiation was coupled to phosphorylation of the EGF-receptor and ERK1/2, this was shown to be HA-dependent as pre-treatment with 4MU prevented downstream events. Paradoxically, when applied exogenously as a culture medium supplement, low molecular weight HA promotes, whereas high molecular weight HA attenuates SMC differentiation. Subsequently, using a bioreactor system, low molecular weight HA was circulated through a decellurised vessel scaffold ex vivo. In contrast to differentiation medium alone the addition of low molecular weight HA promoted migration of stem cells seeded around the outside of the vessel into the media and their differentiation into SMCs, which coincided with localisation of HA and its receptor CD44. Conclusions We demonstrate for the first time that endogenously produced HA is critical for SMC differentiation from stem cells, via activation of EGF-R and ERK1/2. The prospect of maintaining stemness or inducing differentiation in stem cells by manipulation of HA concentration/molecular weight, or by targeting genes activated by HA, may provide new therapies for vascular disease.
ROLE OF HYALURONAN IN PATHOPHYSIOLOGY OF VASCULAR1 ENDOTHELIAL AND SMOOTH MUSCLE CELLS.

A. Passi,Simona Rovera,D. Vigetti,Arianna Parnigoni,M. Viola,E. Karousou,C. Giaroni

DOI: https://doi.org/10.1152/ajpcell.00061.2022

2022-06-27

Abstract:One of the main components of the extracellular matrix (ECM) of the blood vessel is hyaluronic acid or hyaluronan (HA). It is a ubiquitous polysaccharide belonging to the family of glycosaminoglycans, but, differently from other proteoglycan-associated glycosaminoglycans, it is synthesized on the plasma membrane by a family of three HA synthases (HAS). HA can be released as a free polymer in the extracellular space or remain associated with the membrane in the pericellular space via HAS or via binding proteins. In fact, several cell surface proteins can interact with HA working as HA receptors like CD44, RHAMM, and LYVE-1. In physiological conditions, HA is localized in the glycocalyx and in the adventitia and is responsible for the loose and hydrated vascular structure favoring flexibility and allowing the stretching of vessels in response to mechanical forces. During atherogenesis, ECM undergoes dramatic alterations which have a crucial role in lipoprotein retention and in triggering multiple signaling cascades that wake up cells from their quiescent status. HA becomes highly present in the media and neointima favoring smooth muscle cells dedifferentiation, migration, and proliferation that strongly contribute to vessel wall thickening. Further, HA is able to modulate immune cell recruitment both within the vessel wall and on the endothelial cell layer. This review is focused on the effects of HA on vascular cell behavior.

Biology,Medicine
Role of Uric Acid in Vascular Remodeling: Cytoskeleton Changes and Migration in VSMCs

Elisa Russo,Maria Bertolotto,Valentina Zanetti,Daniela Picciotto,Pasquale Esposito,Federico Carbone,Fabrizio Montecucco,Roberto Pontremoli,Giacomo Garibotto,Francesca Viazzi,Daniela Verzola

DOI: https://doi.org/10.3390/ijms24032960

2023-02-03

Abstract:The mechanisms by which hyperuricemia induces vascular dysfunction and contributes to cardiovascular disease are still debated. Phenotypic transition is a property of vascular smooth muscle cells (VSMCs) involved in organ damage. The aim of this study was to investigate the effects of uric acid (UA) on changes in the VSMC cytoskeleton, cell migration and the signals involved in these processes. MOVAS, a mouse VSMC line, was incubated with 6, 9 and 12 mg/dL of UA, angiotensin receptor blockers (ARBs), proteasome and MEK-inhibitors. Migration property was assessed in a micro-chemotaxis chamber and by phalloidin staining. Changes in cytoskeleton proteins (Smoothelin B (SMTB), alpha-Smooth Muscle Actin (αSMA), Smooth Muscle 22 Alpha (SM22α)), Atrogin-1 and MAPK activation were determined by Western blot, immunostaining and quantitative reverse transcription PCR. UA exposition modified SMT, αSMA and SM22α levels (p < 0.05) and significantly upregulated Atrogin-1 and MAPK activation. UA-treated VSMCs showed an increased migratory rate as compared to control cells (p < 0.001) and a re-arrangement of F-actin. Probenecid, proteasome inhibition and ARBs prevented the development of dysfunctional VSMC. This study shows, for the first time, that UA-induced cytoskeleton changes determine an increase in VSMC migratory rate, suggesting UA as a key player in vascular remodeling.
SMC Derived Hyaluronan Modulates Vascular SMC-Phenotype in Murine Atherosclerosis

Felicia Hartmann,Daniel J Gorski,Susanne Homann,Anne Petz,Katherine M Owsiany,Vlad Serbulea,Yu-Qing Zhou,Rebecca A Deaton,Gary K Owens,Jens W Fischer,Alexandra AC Newman,Michelle P Bendeck

DOI: https://doi.org/10.1161/circresaha.120.318479

IF: 23.213

2021-10-08

Circulation Research

Abstract:Rationale: Plaque instability remains poorly understood and new therapeutic approaches to reduce plaque rupture and subsequent clinical events are of great interest. Recent studies revealed an important role of phenotypic switching of smooth muscle cells (SMC) in controlling plaque stability, including extracellular matrix (ECM) deposition. Objective: The aim of this study was to elucidate the role of hyaluronan (HA) derived from SMC-HA synthase 3 (Has3), in phenotypic switching and plaque stability in an animal model of atherosclerosis. Methods and Results: A mouse line with SMC-specific deletion of Has3 and simultaneous SMC lineage tracing (eYFP) on an Apoe-/- background was used. Lineage tracing of SMC with eYFP revealed that SMC-specific deletion of Has3 significantly increased the number of galectin-3 (LGALS3+) "transition-state" SMC and decreased alpha-smooth muscle actin (ACTA2+) SMC. Notably, SMC-Has3 deletion led to significantly increased collagen deposition and maturation within the fibrous cap (FC) and the whole lesion, as evidenced by Picrosirius red staining and LC-PolScope analysis. Single-cell RNA sequencing (scRNA-seq) of brachiocephalic artery (BCA) lesions demonstrated that the loss of SMC-Has3 enhanced the transition of SMC to an Lgals3+, ECM-producing phenotype with elevated acute-phase response gene expression. Experiments using cultured murine aortic SMC revealed that blocking cluster of differentiation-44 (CD44), an important HA binding receptor, recapitulated the enhanced acute-phase response and synthesis of fibrous ECM. Conclusions: These studies provide evidence that the deletion of SMC-Has3 results in an ECM-producing "transition state" SMC phenotype (characterized by LGALS3+ expression), likely via reduced CD44 signaling, resulting in increased collagen formation and maturation, an index consistent with increased plaque stability.

cardiac & cardiovascular systems,peripheral vascular disease,hematology
Structure‐Function Analysis of Ursolic Acid and its Analogs to Identify Their Anti‐inflammatory Mechanism of Action

Huynh Nga Nguyen,Hong Seok Kim,Sarah Ullevig,Reto Asmis

DOI: https://doi.org/10.1096/fasebj.29.1_supplement.390.6

2015-04-01

The FASEB Journal

Abstract:We showed that ursolic acid (UA), a pentacyclic triterpenoid with anti‐inflammatory properties, reduces atherosclerotic lesion size and monocyte dysfunction in diabetic mice. We proposed that UA protects monocytes against metabolic stress‐induced monocyte dysfunction or “priming,” by preventing the induction of Nox4, the rate‐limiting step promoting hyper‐responsiveness to chemoattractants and accelerated chemotaxis induced by metabolic stress. We have also demonstrated that UA rescues MKP‐1 protein expression and activity in metabolically primed cells. The aim of this study was to investigate nine of UA's naturally occurring analogs and identify the structural features of UA required to inhibit monocyte priming and prevent Nox4 induction. We determined the doses (0.03 ‐ 3 μM) at which UA and its analogs blocked metabolic stress‐induced acceleration of chemotaxis in response to MCP‐1 in metabolically primed THP‐1 monocytes. Only the UA analogs hederagenin (IC 50 = 0.64 μM), oleanolic acid (IC 50 = 1.9 μM), and uvaol (IC 50 = 2.46 μM), protected monocytes against metabolic priming. UA was the most potent analog (IC 50 = 0.1 μM). All protective analogs also prevented Nox4 induction and rescued MKP‐1 from degradation. Our data suggests that hederagenin, oleanolic acid and uvaol prevent monocyte priming and dysfunction through the same mechanism as UA and thus may all be atheroprotective. Identifying the structural features responsible for UA's beneficial effects will enable us to develop more potent, dietary supplements for the prevention of atherosclerosis and other monocyte‐mediated diabetic complications. Funding Source : Supported by a grant to RA from the NIH (R01‐AT006885)
Hyaluronan is Crucial for Stem Cell Differentiation into Smooth Muscle Lineage

Russell M. L. Simpson,Xuechong Hong,Mei,Eirini Karamariti,Shirin Issa Bhaloo,Derek Warren,Wei Kong,Yanhua Hu,Qingbo Xu

DOI: https://doi.org/10.1002/stem.2328

IF: 5.845

2016-01-01

Stem Cells

Abstract:Deciphering the extracellular signals that regulate SMC differentiation from stem cells is vital to further our understanding of the pathogenesis of vascular disease and for development of cell-based therapies and tissue engineering. Hyaluronan (HA) has emerged as an important component of the stem cell niche, however its role during stem cell differentiation is a complicated and inadequately defined process. This study aimed to investigate the role of HA in embryonic stem cell (ESC) differentiation toward a SMC lineage. ESCs were seeded on collagen-IV in differentiation medium to generate ESC-derived SMCs (esSMCs). Differentiation coincided with increased HA synthase (HAS) 2 expression, accumulation of extracellular HA and its assembly into pericellular matrices. Inhibition of HA synthesis by 4-methylumbelliferone (4MU), removal of the HA coat by hyaluronidase (HYAL) or HAS2 knockdown led to abrogation of SMC gene expression. HA activates ERK1/2 and suppresses EGFR signaling pathways via its principle receptor, CD44. EGFR inactivation coincided with increased binding to CD44, which was further augmented by addition of high molecular weight (HMW)-HA either exogenously or via HAS2 overexpression through adenoviral gene transfer. HMW-HA-stimulated esSMCs displayed a functional role in vascular tissue engineering ex vivo, vasculogenesis in a matrigel plug model and SMC accumulation in neointimal lesions of vein grafts in mice. These findings demonstrate that HAS2-induced HA synthesis and organization drives ESC-SMC differentiation. Thus, remodeling of the HA microenvironment is a critical step in directing stem cell differentiation toward a vascular lineage, highlighting HA as a potential target for treatment of vascular diseases. Stem Cells 2016;34:1225-1238.
Doctors and unions: is collective bargaining the cure for physicians' labor pains?

K. Stickler,M. Nelson

Abstract:Increasing governmental regulation, the proliferation of alternative health-care options, and a glut of physicians in some areas have substantially affected the way physicians practice medicine today. Health-care consumers are not the only people affected. Where physicians were once their own bosses, many now find themselves as employers of health-care providers. In this new role, physicians are now considering union representation as a vehicle to assert their interests and concerns. This article examines why some doctors favor unionization, why some oppose it, and the legal implications of unionized physicians.
4-Methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy for chronic prostatitis

Jing Chen,Jialin Meng,Chen Jin,Fan Mo,Yang Ding,Xiaomei Gao,Li Zhang,Meng Zhang,Chaozhao Liang

DOI: https://doi.org/10.1002/pros.24205

Abstract:Background: Hyaluronan (HA), an extracellular matrix component, accumulates in most chronic inflammatory tissues. Here, we studied the impact of HA on the pathogenesis of chronic prostatitis. Materials and methods: First, we sorted demographic characteristics and peripheral blood serum samples from patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) to assess the relationship between the levels of HA in peripheral blood serum and the severity of inflammation in patients. Second, we induced an experimental autoimmune prostatitis (EAP) mouse model and treated the mice with 4-methylumbelliferone (4-MU) (200 mg/kg/day). After the mice were sacrificed, RNA from Th1 cells of the mouse spleens was extracted for RNA sequencing. We used weighted gene co-expression network analysis (WGCNA) to identify co-expressed gene modules and hub-gene related to the pathogenesis of EAP. The expression of critical genes associated with the identified pathway was confirmed by using western blot analysis. Results: HA was significantly more highly expressed in CP/CPPS patients than in healthy volunteers and positively correlated with the severity of pain, urination symptoms, and quality of life. Besides, the protein expression of HA was significantly higher in prostate tissues derived from EAP models than in those derived from controls. 4-MU, an oral inhibitor of HA synthesis, relieved immunocyte infiltration to the prostate and significantly reduced the proportion of Th1 cells. Based on the WGCNA, we identified 18 co-expression modules and identified that the Grey60 and brown modules were positively associated with the EAP and negatively associated with the Control and 4-MU-treated groups. Pathway enrichment analyses and western blot assays proved that HA potentially activated the cell cycle pathway, increasing the proportion of Th1 cells promoting chronic prostatitis pathogenesis, while these processes were reversed by 4-MU treatment. Conclusions: Our results suggest that HA is elevated in patients with CP/CPPS compared with healthy controls and that targeting HA through 4-MU suppresses the activity of the cell cycle-related pathway, potentially by decreasing the proportion of Th1 cells and relieving chronic prostatitis. Our findings might inspire the clinical treatment of chronic prostatitis.
Skin-specific knockdown of hyaluronan in mice by an optimized topical 4-methylumbelliferone formulation

Emily H. Steen,Walker D. Short,Hui Li,Umang M. Parikh,Alexander Blum,Natalie Templeman,Nadine Nagy,Paul L. Bollyky,Sundeep G. Keswani,Swathi Balaji

DOI: https://doi.org/10.1080/10717544.2021.1886376

IF: 6.819

2021-01-01

Drug Delivery

Abstract:<span>Hyaluronan (HA) is abundant in the skin; while HA can be synthesized by the synthases (HAS1-3), HAS2 is the leading contributor. Dysregulation and accumulation of HA is implicated in the pathogenesis of diseases such as keloid scarring, lymphedema and metastatic melanoma. To understand how HA synthesis contributes to skin physiology, and pathologic and fibrotic disorders, we propose the development of skin-specific HA inhibition model, which tests an optimal delivery system of topical 4-methylumbelliferone (4-MU).A design-of-experiments (DOE) approach was employed to develop an optimal 4-MU skin-delivery formulation comprising propylene glycol, ethanol, and water, topically applied to dorsal skin in male and female C57BL/6J wildtype mice to determine the effect on HAS gene expression and HA inhibition. Serum and skin samples were analyzed for HA content along with analysis of expression of HAS1-3, hyaluronidases (HYAL 1-2), and KIAA1199.Using results from DOE and response surface methodology with genetic algorithm optimization, we developed an optimal topical 4-MU formulation to result in ∼70% reduction of HA in dorsal skin, with validation demonstrating ∼50% reduction in HA in dorsal skin. 4-MU topical application resulted in significant decrease in skin HAS2 expression in female mice only. Histology showed thicker dermis in male mice, whereas female mice had thinner dermal layer with more adiposity; and staining for HA-binding protein showed that topical 4-MU resulted in breakdown in HA.Our data suggest a topical 4-MU formulation-based dermal HA inhibition model that would enable elucidating the skin-specific effects of HA in normal and pathologic states.</span>

pharmacology & pharmacy
Berberine Suppresses In Vitro Migration Of Human Aortic Smooth Muscle Cells Through The Inhibitions Of Mmp-2/9, U-Pa, Ap-1, And Nf-Kappa B

Su-Jian Liu,Cai-Xia Yin,Ming-Chao Ding,Shao-You Xia,Qin-Min Shen,Ji-Dong Wu

DOI: https://doi.org/10.5483/BMBRep.2014.47.7.186

2014-01-01

BMB Reports

Abstract:Berberine, a type of isoquinoline alkaloid isolated from Chinese medicinal herbs, has been reported to have various pharmacological activities. Studies have demonstrated that berberine has beneficial effects on vascular remodeling and alleviates restenosis after vascular injury. However, its mechanism of action on vascular smooth muscle cell migration is not fully understood. We therefore investigated the effect of berberine on human aortic smooth muscle cell (HASMC) migration. Boyden chamber assay was performed to show that berberine inhibited HASMC migration dose-dependently. Real-time PCR and Western blotting analyses showed that levels of matrix metalloproteinase (MMP)-2, MMP-9, and urokinase-type plasminogen activator (u-PA) were reduced by berberine at both the mRNA and protein levels. Western blotting assay further confirmed that activities of c-Fos, c-Jun, and NF-kappa B were significantly attenuated. These results suggest that berberine effectively inhibited HASMC migration, possibly by down-regulating MMP-2, MMP-9, and u-PA; and interrupting AP-1 and NF-kappa B mediated signaling pathways.
A Systematic Study of the Effect of Different Molecular Weights of Hyaluronic Acid on Mesenchymal Stromal Cell-Mediated Immunomodulation

Alejandro Gómez-Aristizábal,Kyung-Phil Kim,Sowmya Viswanathan

DOI: https://doi.org/10.1371/journal.pone.0147868

IF: 3.7

2016-01-28

PLoS ONE

Abstract:INTRODUCTION: Osteoarthritis (OA) is associated with chronic inflammation, and mesenchymal stromal cells (MSCs) have been shown to provide pain relief and reparative effects in clinical investigations. MSCs are often delivered with hyaluronic acid (HA), although the combined mechanism of action is not fully understood; we thus investigated the immunomodulatory effects of combining MSCs with different molecular weights (MW) of HA.METHODS: HAs with MWs of 1.6 MDa (hHA), 150 kDa or 7.5 kDa, were added to MSCs alone or MSC-immune cell co-cultures. Gene expression analyses, flow cytometry and cytokine measurements were assessed to determine the effect of HAs on the MSC interactions with immune cells.RESULTS: MSCs in the presence of HAs, in both normal and lymphocyte-conditioned medium, showed negligible changes in gene expression. While addition of hHA resulted in increased proliferation of activated lymphocytes, both in the presence and absence of MSCs, the overall combined effect was a more regulated, homeostatic one; this was supported by higher ratios of secreted IL10/IFNγ and IL10/IL2, in lymphocyte cultures, than with lower MW HAs or no HA, both in the presence and absence of MSCs. In addition, examination of monocyte-derived macrophages showed an increased M2 macrophage frequency (CD14+CD163+CD206+) in the presence of hHA, both with and without MSCs.CONCLUSIONS: hHA produces a less pro-inflammatory environment than lower MW HAs. Moreover, combining hHA with MSCs has an additive effect on the MSC-mediated immunomodulation, suggestive of a more potent combination treatment modality for OA.

multidisciplinary sciences
Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts

Erika Galgoczi,Florence Jeney,Monika Katko,Annamaria Erdei,Annamaria Gazdag,Livia Sira,Miklos Bodor,Eszter Berta,Bernadett Ujhelyi,Zita Steiber,Ferenc Gyory,Endre V. Nagy

DOI: https://doi.org/10.1167/iovs.61.2.27

2020-02-21

Investigative Opthalmology and Visual Science

Abstract:Hyaluronan (HA) overproduction by orbital fibroblasts (OFs) is a major factor in the pathogenesis of Graves' orbitopathy (GO). 4-methylumbelliferone (4-MU) is an inhibitor of HA synthesis in different cell types in vitro and has beneficial effects in animal models of autoimmune diseases.HA production and mRNA expression of HA synthases (HAS1, HAS2, and HAS3) and hyaluronidases (HYAL1 and HYAL2) were measured in the presence and absence of 4-MU in unstimulated and transforming growth factor-β-stimulated fibroblasts from GO orbital (n = 4), non-GO orbital (n = 4), and dermal origin (n = 4).The 4-MU treatment (1 mM) for 24 hours resulted in an average 87% reduction (P < 0.001) of HA synthesis, decreased the expression of the dominant HAS isoform (HAS2) by 80% (P < 0.0001), and increased the HYAL2 expression by 2.5-fold (P < 0.001) in control OFs, GO OFs, and dermal fibroblasts (DFs) regardless of the origin of the cells. The proliferation rate of all studied cell lines was reduced to an average 16% by 4-MU (P < 0.0001) without any effects on cell viability. HA production stimulated by transforming growth factor-β was decreased by 4-MU via inhibition of stimulated HAS1 expression in addition to the observed effects of 4-MU in unstimulated cases. Characteristics of HA synthesis inhibition by 4-MU did not differ in OFs compared with DFs.4-MU has been found to inhibit the HA synthesis and the proliferation rate in OFs in vitro, adding it to the list of putative therapeutic agents in a disease the cure of which is largely unresolved.
Control of the synthesis, activity, and turnover of enzymes of sulfur metabolism in Neurospora crassa.

G. Marzluf

DOI: https://doi.org/10.1016/0003-9861(72)90090-2

IF: 4.114

1972-06-01

Archives of Biochemistry and Biophysics

Abstract:
Restoration of ARA metabolic disorders in vascular smooth muscle cells alleviates intimal hyperplasia

Hui Wu,Dai Li,Chen-Yu Zhan,Lin-Li Huang,You-Jie Zeng,Tian-Ge Chen,Ke Yu,Jia-Wei Meng,Yu-Xing Lin,Ren Guo,Yong Zhou,Ge Gao

DOI: https://doi.org/10.1016/j.ejphar.2024.176824

IF: 5.195

2024-09-11

European Journal of Pharmacology

Abstract:Intimal hyperplasia (IH) is an innegligible issue for patients undergoing interventional therapy. The proliferation and migration of vascular smooth muscle cells (VSMCs) induced by platelet-derived growth factor-BB (PDGF-BB) are critical events in the development of IH. While the exact mechanism and effective target for IH needs further investigation. Metabolic disorders of arachidonic acid (ARA) are involved in the occurrence and progression of various diseases. In this study, we found that the expressions of soluble epoxide hydrolase (sEH) and cyclooxygenase-2 (COX-2) were significantly increased in the VSMCs during balloon injury-induced IH. Then, we employed a COX-2/sEH dual inhibitor PTUPB to increase the concentration of epoxyeicosatrienoic acids (EETs) while prevent the release of pro-inflammatory prostaglandins. Results showed that PTUPB treatment significantly reduced neointimal thickening induced by balloon injury in rats in vivo and inhibited PDGF-BB-induced proliferation and migration of VSMCs in vitro . Our results showed that PTUPB may reverse the phenotypic transition of VSMCs by inhibiting Pttg1 expression. In conclusion, we found that the dysfunction of ARA metabolism in VSMCs contributes to IH, and the COX-2/sEH dual inhibitor PTUPB attenuates IH progression by reversing the phenotypic switch in VSMC through the Sirt1/Pttg1 pathway.

pharmacology & pharmacy
Inhibitory Effect of Dehydrozingerone on Vascular Smooth Muscle Cell Function

Yizhen Liu,Julia Dolence,Jun Ren,M. N. A. Rao,Nair Sreejayan

DOI: https://doi.org/10.1097/fjc.0b013e31818aed93

2007-01-01

The FASEB Journal

Abstract:Background/Aims: Growth factor and oxidative stress-mediated migration and proliferation of vascular smooth muscle cells (VSMCs) play a key role in the pathogenesis of atherosclerosis. The objective of this study was to assess the ability of dehydrozingerone, a structural analog of curcumin, to inhibit PDGF-stimulated vascular functions in VSMCs.Methods: VSMCs isolated from adult rats were treated with dehydrozingerone (0 to 50 p,M) before challenge with PDGF (10 ng/mL) and migration, proliferation, and collagen synthesis were assayed by transwell-migration, thymidine-, and L-proline-incorporation assays, respectively. Phosphorylation of PDGF-receptor (PDGFR) and Akt were assessed by Western blotting. Cellular protein tyrosine phosphatase (PTP) activity was determined by the extent of p-nitro-phenyl phosphate hydrolysis.Results: Dehydrozingerone elicited a concentration-dependent inhibition of PDGF-stimulated VSMC migration, proliferation, collagen synthesis, and PDGF/H2O2-stimulated phosphorylation of PDGFR-beta and downstream Akt. Dehydrozingerone also inhibited H2O2-mediated oxidation of PTP.Conclusions: Dehydrozingerone is a potent inhibitor of growth factor/ H2O2-stimulated VSMC functions and may play a critical role in regulating these events after vascular injury. Inhibition of oxidation of cellular phosphatases may represent one of the mechanisms by which dehydrozingerone inhibits these VSMC functions. Inability of the structural analog isoeugenol to inhibit PDGF-signaling suggests that the carbonyl side chain may be necessary for activity.
Effects of mycophenolic acid on proliferation and collagen I of unstimulated or stimulated vascular smooth muscle cells

Xiao Yuefei,Zhang Youkang

DOI: https://doi.org/10.3969/j.issn.1005-2194.2006.06.016

2006-01-01

Abstract:Objective To develop stable cultures of human umbilical cord vascular endothelial cells(ECs)and smooth muscle cells(SMCs)in order to investigate the effect of mycophenolic acid(MPA)on proliferation and collagen Ⅰ production of SMCs.Methods From Sep.2002 to Sep.2003,ECs were cultured from human umbilical cord veins,and SMCs from arteries.Productions of endothelial cells conditioned medium(ECCM)was obtained from serum free Dulbecco's modified eagle medium(DMEM)with or without MPA(0,0.31,1.25,2.50,5.00,10.00 μg·mL -1).Proliferation of SMCs was performed with 3H-thymidine incorporation scintillation,and collagen Ⅰ production of SMCs was measured with enzyme-linked immunosorbent assay.Results (1)The 3H-thymidine incorporation increased significantly(P < 0.01)to(170.6 ±13.7)% and the collagen Ⅰ production to(128.0 ±7.7)%(P < 0.01)after SMCs were stimulated by ECCM without MPA compared to the control condition;(2)Direct effect of MPA on unstimulated SMCs:Significant reduction of 3H-thymidine incorporation of unstimulated SMCs was found only at MPA 10 μg·mL -1 ,and the reduction was(29.9 ±3.5)%.However,significant dose-dependent reduction of collagen Ⅰ production was found at all concentration investigated,and the highest reduction was(81.0±4.8)% at MPA 10 μg·mL -1;(3)Significant inhibitory effect of MPA on 3H-thymidine incorporation of SMCs stimulated with ECCM at all concentration applied was independent of MPA added during or after the production of the conditioned medium.Similarly MPA exerted a significant inhibitory effect on collagen Ⅰ production of stimulated SMCs independent of MPA added during or after the production of the conditioned medium.Conclusion MPA exerts significant inhibition to some degree on proliferation of human umbilical cord vascular SMCs,and greatly inhibits collagen Ⅰ production of SMCs.
Urate‐lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse model of induced carotid atherosclerosis

Jie Lu,Mingshu Sun,Xinjiang Wu,Xuan Yuan,Zhen Liu,Xiaojie Qu,Xiaopeng Ji,Tony R. Merriman,Changgui Li

DOI: https://doi.org/10.1111/febs.14768

2019-02-09

Abstract:Hyperuricemia (HU) is a cause of gout. Clinical studies show a link between HU and cardiovascular disease. However, the role of soluble serum urate (SU) on atherosclerosis development remains elusive. We aimed to use a new HU mouse model [Uricase/Uox knockout (KO)] to further investigate the relationship between HU and atherosclerosis. A mouse model by perivascular collar placement of induced carotid atherosclerosis was established in male Uox-KO mice. The Uox-KO mice had elevated SU levels and enhanced levels of atherosclerosis inflammatory response proteins. In contrast, Uox-KO mice with carotid atherosclerosis showed severe neointimal changes in histology staining consistent with increases in intimal area and increases in proliferating cell nuclear antigen (PCNA)- and F4/80-positive cells. Allopurinol reduced neointimal areas induced by the perivascular collar in hyperuricemic mice, accompanied by decreased expression of PCNA- and F4/80-positive cells. Urate-lowering treatment alleviated atherosclerosis inflammatory response factors and reactive oxygen species (ROS) intensities in both collar placement Uox-KO mice and urate-stimulated human umbilical vein endothelial cells (HUVECs). In vitro results using HUVECs showed ROS was induced by urate and ROS induction was abrogated using antioxidants. These data demonstrate that urate per se does not trigger atherosclerosis intima lesions in male mice. Urate worsens carotid neointimal lesions induced by the perivascular collar and urate-lowering therapy partially abrogates the effects. The current study warrants clinical studies on the possible benefits of urate-lowering therapy in atherosclerosis patients with HU.
Effects of Dehydroepiandrosterone on the Interaction Between Endothelial Cells and Monocytes after Endothelial Cell Injury

HAO Qun,LIANG Yuan-jiao,ZHANG Cheng,LI Da-jin,WANG Hao

DOI: https://doi.org/10.3969/j.issn.1008-8199.2012.06.003

2012-01-01

Abstract:Objective Dehydroepiandrosterone(DHEA) is the most abundant steroid secreted by adrenal glands in adults.This study was to investigate the effect of DHEA on the interaction between endothelial cells and monocytes after endothelial cell injury induced by oxidized low-density lipoprotein(ox-LDL).Methods Using cultured human umbilical vein endothelial cells(HUVECs) as target cells,we added ox-LDL to the endothelial cell culture and different concentrations of DHEA to the experimental architecture,and analyzed the adherence of monocyte-like cell line U937 to HUVECs.We determined the contents of nitric oxide(NO) and monocyte chemoattractant protein(MCP-1) in the conditioned medium of HUVECs(EC-CM) and the expression of intercellular adhesion molecule-1(ICAM-1),and measured the levels of vascular cell adhesion molecule-1(VCAM-1) and E-selectin of HUVECs.We used EC-CM to act on U937 cells and detected the expressions of CCR2,LFA-1 and VLA-4 mRNA in them by RT-PCR.Results DHEA significantly promoted NO synthesis,suppressed MCP-1 secretion in endothelial cells and decreased ICAM-1 and VCAM-1 expressions in HUVECs.The EC-CM treated with DHEA obviously inhibited the expressions of CCR2,LFA-1 and VLA-4 mRNA in U937 cells.Conclusion Dehydroepiandrosterone appears to have a protective effect on vein endothelial cells,probably by inhibiting the secretion of MCP-1,down-regulating the expressions of ICAM-1 and VCAM-1,and suppressing the recruitment and adherence of monocytes to the endothelial cells.

Effect of sperm-immobilizing antibodies bound to the surface of ejaculated human spermatozoa on sperm motility in immunologically infertile men.

Effects of Homocysteine on the Expression of Matrix Metalloproteinase-2 in Rat Vascular Smooth Muscle Cells

Inhibitor of Hyaluronic Acid Synthesis 4-Methylumbelliferone Suppresses the Secretory Processes That Ensure the Invasion of Neutrophils into Tissues and Induce Inflammation

198 HYALURONAN IS REQUIRED FOR SMOOTH MUSCLE CELL DIFFERENTIATION FROM STEM CELLS

ROLE OF HYALURONAN IN PATHOPHYSIOLOGY OF VASCULAR1 ENDOTHELIAL AND SMOOTH MUSCLE CELLS.

Role of Uric Acid in Vascular Remodeling: Cytoskeleton Changes and Migration in VSMCs

SMC Derived Hyaluronan Modulates Vascular SMC-Phenotype in Murine Atherosclerosis

Structure‐Function Analysis of Ursolic Acid and its Analogs to Identify Their Anti‐inflammatory Mechanism of Action

Hyaluronan is Crucial for Stem Cell Differentiation into Smooth Muscle Lineage

Doctors and unions: is collective bargaining the cure for physicians' labor pains?

4-Methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy for chronic prostatitis

Skin-specific knockdown of hyaluronan in mice by an optimized topical 4-methylumbelliferone formulation

Berberine Suppresses In Vitro Migration Of Human Aortic Smooth Muscle Cells Through The Inhibitions Of Mmp-2/9, U-Pa, Ap-1, And Nf-Kappa B

A Systematic Study of the Effect of Different Molecular Weights of Hyaluronic Acid on Mesenchymal Stromal Cell-Mediated Immunomodulation

Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts

Control of the synthesis, activity, and turnover of enzymes of sulfur metabolism in Neurospora crassa.

Restoration of ARA metabolic disorders in vascular smooth muscle cells alleviates intimal hyperplasia

Inhibitory Effect of Dehydrozingerone on Vascular Smooth Muscle Cell Function

Effects of mycophenolic acid on proliferation and collagen I of unstimulated or stimulated vascular smooth muscle cells

Urate‐lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse model of induced carotid atherosclerosis

Effects of Dehydroepiandrosterone on the Interaction Between Endothelial Cells and Monocytes after Endothelial Cell Injury